Open an account

Senseonics Holdings

SENS · NYSE American

$8.21+$0.195 (+2.43%)TodayMarket closed ·
Prev close $8.02

About SENS

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. The company is headquartered in Germantown, Maryland and currently employs 130 full-time employees. The company went IPO on 2015-03-04. Its glucose monitoring (CGM) systems Eversense 365 and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. Its CGM systems are indicated for continually measuring glucose levels for up to 365 days for Eversense 365 and 180 days for Eversense E3 in persons with diabetes age 18 and older. Eversense consists of three primary components: a small sensor inserted subcutaneously under the skin by a healthcare provider; an external removable smart transmitter that receives, assesses and relays data from the sensor and provides vibratory alerts; and a mobile app that receives data from the transmitter and provides real-time glucose readings, alerts and other data the person's mobile device.

Employees
130
Headquarters
Germantown, Maryland
Listed
Mar 4, 2015
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
senseonics.com

SENS key statistics

Market cap
434.10M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
667.28K
Volume
366.26K
Open price
$8.02
High today
$8.40
Low today
$7.92
52 Week high
$10.64
52 Week low
$4.79

Senseonics Holdings (SENS) at a glance

Senseonics Holdings (SENS) last traded at $8.21, with a market cap of 434.10M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $7.92 and $8.40. The current price is 3.7% above the day's low and 2.3% below its high.

Volume so far is 366.26K shares, below the average of 667.28K shares a day.

Over the past year Senseonics Holdings has ranged from $4.79 to $10.64, and now sits 58% of the way up that range.

Senseonics Holdings met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported -$0.63 per share against an estimate of -$0.6372.

The average analyst price target is $14.48, 76.4% above the current price, from 6 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

67%of 6 analyst ratings say Buy
  • Buy66.7%
  • Hold33.3%
  • Sell0.0%
Price target · 7 analystsAvg $14.48
Low
$8.08
Now
$8.21
High
$18.90

SENS earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 13.0% on average.

  1. Q3 FY24: reported -$0.80 per share against an estimate of -$0.7018
  2. Q4 FY24: reported -$0.40 per share against an estimate of -$0.6069
  3. Q1 FY25: reported -$0.40 per share against an estimate of -$0.4692
  4. Q2 FY25: reported -$0.40 per share against an estimate of -$0.408
  5. Q3 FY25: reported -$0.43 per share against an estimate of -$0.2855
  6. Q4 FY25: reported -$0.47 per share against an estimate of -$0.443
  7. Q1 FY26: reported -$0.71 per share against an estimate of -$0.6907
  8. Q2 FY26: reported -$0.63 per share against an estimate of -$0.6372

SENS news

  • Avi Kapoor

    Jim Cramer Says Buy Carpenter Technology, Calls This IT Services Stock a 'Value Trap'

  • 12 Health Care Stocks Moving In Friday's Intraday Session

  • Press releaseGlobe Newswire

    Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems

  • Henry Khederian

    Senseonics Shares Sink Friday: What's Driving The Move?

  • 12 Health Care Stocks Moving In Friday's Pre-Market Session

  • 12 Health Care Stocks Moving In Thursday's After-Market Session

  • Press releasePRNewswire

    The Quiet Rule Change Tilting $10B Toward Medtech's Most Validated Platforms

  • Press releasePRNewswire

    MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value

Similar companies

Companies in the same industry as Senseonics Holdings

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.